Canertinib (CI-1033)
Canertinib (CI-1033) 是一种不可逆的酪氨酸激酶抑制剂,对 EGFR (IC50 0.8 nM)、HER-2 (IC50 19 nM) 和 ErbB-4 (IC50 7 nM) 有活性。
全国免运费, 顺丰次日达
重要通知:仅供研究使用。我们不向患者销售。
重要通知:仅供研究使用。我们不向患者销售。
Discription | Canertinib (CI-1033) is an irreversible tyrosine-kinase inhibitor with activity against EGFR (IC50 0.8 nM), HER-2 (IC50 19 nM) and ErbB-4 (IC50 7 nM). | |||||
---|---|---|---|---|---|---|
Targets |
|
|||||
Cell Research |
|
目录号 | A10211 |
---|---|
分子式 | C24H25ClFN5O3 |
分子量 | 485.9 |
CAS号 | 267243-28-7 |
SMILES | C=CC(=O)NC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4 |
其他名称 | PD-183805 |
储存条件 | Store lyophilized at -20ºC, keep desiccated. |
In vitro (25°C) | DMSO | 2 mg/mL (4.11 mM) | |
Water | Insoluble | ||
Ethanol | 8 mg/mL (16.46 mM) | ||
In vivo | 30% propylene glycol, 5% Tween 80, 65% D5W | 9 mg/mL | |
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 20.58 mL | 102.9 mL | 205.8 mL |
0.5 mM | 4.12 mL | 20.58 mL | 41.16 mL |
1 mM | 2.06 mL | 10.29 mL | 20.58 mL |
5 mM | 0.41 mL | 2.06 mL | 4.12 mL |
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2